In 2012, Dr. Martin Lange performed the practical phase of his Master program at Harvard Medical School, focusing on smooth muscle cells from different arteries and their susceptibility to contributing to atherosclerosis. He received his master’s degree in biomedical science in 2013. Afterwards, he completed a PhD program at the Max Planck Institute for molecular biomedicine (Münster, Germany), where he used the zebrafish as a model organism to study the influence of duplicated vegfa genes during blood vessel development in the central nervous system. Since 2019, Dr. Lange has been a postdoctoral scientist in the Eichmann lab at the YCVRC, where he extends his research on VEGF signaling towards the mouse lymphatic and cardiovascular systems using inducible genetic deletions and various cell culture models. His goal is to understand and control the junctional plasticity of lymphatic and blood vessel endothelial cells. His research topics mainly focus on vascular development, vascular homeostasis, endothelial cells, lymphatics, and cell junctions.
Prof. Dr. Edda Tobiasch is a molecular biologist who graduated from the biology department at Technical University Kaiserslautern. Dr. Tobiasch worked as a postdoc on signal transduction pathways at the German Cancer Research Center (DKFZ) in Heidelberg, the Research Center Karlsruhe, and the University of Heidelberg. She was an instructor at Harvard Medical School, Boston, USA, and is now a professor at the Department of Natural Sciences, Bonn-Rhine-Sieg University of Applied Sciences. She was awarded "Outstanding Scientific Research" at the DKFZ (1993), "External Expert (2008) and Internal Expert (2009), a Foreign Member of the Ph.D. School," and "Visiting Professor" (2011) at the University Palermo, Italy. She is a member of the Steering Committee for the Stem Cell Network in North Rhine Westphalia.
